{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T01:44:46Z","timestamp":1795052686828,"version":"4.10.2"},"reference-count":61,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T00:00:00Z","timestamp":1714694400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["RS-2023-00209828"],"award-info":[{"award-number":["RS-2023-00209828"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002641","name":"Konkuk University - Seoul Campus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002641","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.vaccine.2024.04.088","type":"journal-article","created":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T22:44:12Z","timestamp":1715208252000},"page":"3756-3767","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Efficacy of live and inactivated recombinant Newcastle disease virus vaccines expressing clade 2.3.4.4b H5 hemagglutinin against H5N1 highly pathogenic avian influenza in SPF chickens, Broilers, and domestic ducks"],"prefix":"10.1016","volume":"42","author":[{"given":"Deok-Hwan","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-hun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jei-hyun","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-yun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-un","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyukchae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2918-2349","authenticated-orcid":false,"given":"Andrew Y","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Yeon","family":"Hyeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3106-3712","authenticated-orcid":false,"given":"Sungsu","family":"Youk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Seon","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.04.088_b0005","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.coviro.2016.02.005","article-title":"Emergence and dissemination of clade 2.3.4.4 H5Nx influenza viruses-how is the Asian HPAI H5 lineage maintained","volume":"16","author":"Claes","year":"2016","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.vaccine.2024.04.088_b0010","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1126\/science.aaf8852","volume":"354","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2024.04.088_b0015","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4142\/jvs.2017.18.S1.269","article-title":"Evolution, global spread, and pathogenicity of highly pathogenic avian influenza H5Nx clade 2.3.4.4","volume":"18","author":"Lee","year":"2017","journal-title":"J Vet Sci"},{"key":"10.1016\/j.vaccine.2024.04.088_b0020","first-page":"12","article-title":"Highly Pathogenic Avian Influenza A(H5N1) Virus Clade 2.3.4.4b in Wild Birds and Live Bird Markets","author":"El-Shesheny","year":"2022","journal-title":"Egypt Pathogens"},{"key":"10.1016\/j.vaccine.2024.04.088_b0025","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.3201\/eid2805.220318","article-title":"Intercontinental Movement of Highly Pathogenic Avian Influenza A(H5N1) Clade 2.3.4.4 Virus to the United States, 2021","volume":"28","author":"Bevins","year":"2022","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2024.04.088_b0030","doi-asserted-by":"crossref","first-page":"e2252510","DOI":"10.1080\/22221751.2023.2252510","article-title":"Emergence of a new genotype of clade 2.3.4.4b H5N1 highly pathogenic avian influenza A viruses in Bangladesh. Emerg","volume":"12","author":"Barman","year":"2023","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2024.04.088_b0035","first-page":"14","article-title":"Detection of New H5N1 High Pathogenicity Avian Influenza Viruses in Winter 2021\u20132022 in the Far East, Which Are Genetically Close to Those in Europe","author":"Isoda","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2024.04.088_b0040","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1080\/22221751.2022.2088407","article-title":"Global dissemination of H5N1 influenza viruses bearing the clade 2.3.4.4b HA gene and biologic analysis of the ones detected in China","volume":"11","author":"Cui","year":"2022","journal-title":"Emerging Microbes Infect"},{"key":"10.1016\/j.vaccine.2024.04.088_b0045","first-page":"15","article-title":"The Molecular Epidemiology of Clade 2.3.4.4B H5N1 High Pathogenicity Avian Influenza in Southern Africa, 2021\u20132022","author":"Abolnik","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2024.04.088_b0050","doi-asserted-by":"crossref","first-page":"2220569","DOI":"10.1080\/22221751.2023.2220569","article-title":"Detection and phylogenetic analysis of highly pathogenic A\/H5N1 avian influenza clade 2.3.4.4b virus in Chile, 2022. Emerg","volume":"12","author":"Jimenez-Bluhm","year":"2023","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2024.04.088_b0055","doi-asserted-by":"crossref","first-page":"e3255","DOI":"10.1111\/tbed.14551","article-title":"Emergence of clade 2.3.4.4b novel reassortant H5N1 high pathogenicity avian influenza virus in South Korea during late 2021","volume":"69","author":"Sagong","year":"2022","journal-title":"Transbound Emerg Dis"},{"key":"10.1016\/j.vaccine.2024.04.088_b0060","first-page":"12","article-title":"Emergence of Highly Pathogenic Avian Influenza A Virus (H5N1) of Clade 2.3.4.4b in Egypt, 2021\u20132022","author":"Mosaad","year":"2023","journal-title":"Pathogens"},{"key":"10.1016\/j.vaccine.2024.04.088_b0065","doi-asserted-by":"crossref","unstructured":"Youk S, Torchetti MK, Lantz K, Lenoch JB, Killian ML, Leyson C, et al. H5N1 highly pathogenic avian influenza clade 2.3.4.4b in wild and domestic birds: Introductions into the United States and reassortments, December 2021-April 2022. Virology. 2023;587:109860.","DOI":"10.1016\/j.virol.2023.109860"},{"key":"10.1016\/j.vaccine.2024.04.088_b0070","doi-asserted-by":"crossref","first-page":"5489","DOI":"10.1038\/s41467-023-41182-0","article-title":"Highly pathogenic avian influenza A (H5N1) in marine mammals and seabirds in Peru","volume":"14","author":"Leguia","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2024.04.088_b0075","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.3201\/eid2912.230464","article-title":"Highly Pathogenic Avian Influenza A(H5N1) Virus Clade 2.3.4.4b Infections in Wild Terrestrial Mammals, United States, 2022","volume":"29","author":"Elsmo","year":"2023","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2024.04.088_b0080","doi-asserted-by":"crossref","first-page":"e0286722","DOI":"10.1128\/spectrum.02867-22","article-title":"Highly Pathogenic Avian Influenza H5N1 Virus Infections in Wild Red Foxes (Vulpes vulpes) Show Neurotropism and Adaptive Virus Mutations","volume":"11","author":"Bordes","year":"2023","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.vaccine.2024.04.088_b0085","doi-asserted-by":"crossref","first-page":"786","DOI":"10.3201\/eid2904.221538","article-title":"Highly Pathogenic Avian Influenza A(H5N1) Virus Outbreak in New England Seals","volume":"29","author":"Puryear","year":"2023","journal-title":"United States Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2024.04.088_b0090","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.vaccine.2022.11.012","article-title":"Evaluation of three hemagglutinin-based vaccines for the experimental control of a panzootic clade 2.3.4.4b A(H5N8) high pathogenicity avian influenza virus in mule ducks","volume":"41","author":"Niqueux","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.04.088_b0095","doi-asserted-by":"crossref","first-page":"7369","DOI":"10.1016\/j.vaccine.2023.10.070","article-title":"Efficacy of inactivated and RNA particle vaccines against a North American Clade 2.3.4.4b H5 highly pathogenic avian influenza virus in chickens","volume":"41","author":"Spackman","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.04.088_b0100","first-page":"e08271","article-title":"Vaccination of poultry against highly pathogenic avian influenza - part 1. Available vaccines and vaccination strategies","volume":"21","author":"Nielsen","year":"2023","journal-title":"Efsa j"},{"key":"10.1016\/j.vaccine.2024.04.088_b0105","first-page":"11","article-title":"Immunogenicity and Cross-Protective Efficacy Induced by an Inactivated Recombinant Avian Influenza A\/H5N1 (Clade 2.3.4.4b) Vaccine against Co-Circulating Influenza A\/H5Nx Viruses","author":"Mahmoud","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2024.04.088_b0110","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.virol.2013.06.005","article-title":"Emergence of multiple clade 2.3.2.1 influenza A (H5N1) virus subgroups in Vietnam and detection of novel reassortants","volume":"444","author":"Creanga","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2024.04.088_b0115","article-title":"Genetic evolution and transmission dynamics of clade 2.3.2.1a highly pathogenic avian influenza A\/H5N1 viruses in Bangladesh","volume":"6: veaa046","author":"Kwon","year":"2020","journal-title":"Virus Evol"},{"key":"10.1016\/j.vaccine.2024.04.088_b0120","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/tbed.13430","article-title":"Genetic and pathogenic characteristics of clade 2.3.2.1c H5N1 highly pathogenic avian influenza viruses isolated from poultry outbreaks in Laos during 2015\u20132018","volume":"67","author":"Park","year":"2020","journal-title":"Transbound Emerg Dis"},{"key":"10.1016\/j.vaccine.2024.04.088_b0125","doi-asserted-by":"crossref","first-page":"443","DOI":"10.20506\/rst.19.2.1231","article-title":"Newcastle disease and other avian paramyxoviruses","volume":"19","author":"Alexander","year":"2000","journal-title":"Rev Sci Tech"},{"key":"10.1016\/j.vaccine.2024.04.088_b0130","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13567-022-01118-w","article-title":"Current situation and future direction of Newcastle disease vaccines","volume":"53","author":"Hu","year":"2022","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2024.04.088_b0135","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3390\/vaccines8020222","article-title":"Newcastle Disease Virus as a Vaccine Vector for 20 Years: A Focus on Maternally Derived Antibody Interference","volume":"8","author":"Hu","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2024.04.088_b0140","article-title":"Live Recombinant NDV-Vectored H5 Vaccine Protects Chickens and Domestic Ducks From Lethal Infection of the Highly Pathogenic H5N6 Avian Influenza Virus","volume":"8","author":"Lee","year":"2021","journal-title":"Front Vet Sci"},{"key":"10.1016\/j.vaccine.2024.04.088_b0145","series-title":"Chapter 3.3.4: Avian influenza","author":"Oie","year":"2021"},{"key":"10.1016\/j.vaccine.2024.04.088_b0150","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/978-1-4939-0758-8_12","article-title":"Avian influenza virus isolation, propagation, and titration in embryonated chicken eggs","author":"Spackman","year":"2014","journal-title":"Animal influenza virus"},{"key":"10.1016\/j.vaccine.2024.04.088_b0155","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1637\/0005-2086-47.s3.1079","article-title":"Development of real-time RT-PCR for the detection of avian influenza virus","volume":"47","author":"Spackman","year":"2003","journal-title":"Avian Dis"},{"key":"10.1016\/j.vaccine.2024.04.088_b0160","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS12","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2024.04.088_b0165","first-page":"e08039","article-title":"Avian influenza overview March - April 2023","volume":"21","author":"Adlhoch","year":"2023","journal-title":"Efsa j"},{"key":"10.1016\/j.vaccine.2024.04.088_b0170","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s10393-013-0861-3","article-title":"Success factors for avian influenza vaccine use in poultry and potential impact at the wild bird-agricultural interface","volume":"11","author":"Swayne","year":"2014","journal-title":"Ecohealth"},{"key":"10.1016\/j.vaccine.2024.04.088_b0175","unstructured":"IABS. INTERNATIONAL ALLIANCE FOR BIOLOGICAL STANDARDIZATION (IABS) CONFERENCE ON VACCINATION STRATEGIES TO PREVENT AND CONTROL HIGH PATHOGENICITY AVIAN INFLUENZA: PARIS. International alliance for biological standardization; 2022."},{"key":"10.1016\/j.vaccine.2024.04.088_b0180","doi-asserted-by":"crossref","unstructured":"Criado MF, M SES, Lee DH, Salge CAL, Spackman E, Donis R, et al. Cross-Protection by Inactivated H5 Prepandemic Vaccine Seed Strains against Diverse Goose\/Guangdong Lineage H5N1 Highly Pathogenic Avian Influenza Viruses. J Virol. 2020;94.","DOI":"10.1128\/JVI.00720-20"},{"key":"10.1016\/j.vaccine.2024.04.088_b0185","doi-asserted-by":"crossref","first-page":"9697","DOI":"10.1038\/s41598-018-28057-x","article-title":"Efficacy of commercial vaccines against newly emerging avian influenza H5N8 virus in Egypt","volume":"8","author":"Kandeil","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2024.04.088_b0190","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0378-1135(00)00176-0","article-title":"Vaccines protect chickens against H5 highly pathogenic avian influenza in the face of genetic changes in field viruses over multiple years","volume":"74","author":"Swayne","year":"2000","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2024.04.088_b0195","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.dci.2013.04.012","article-title":"Immune responses of poultry to Newcastle disease virus","volume":"41","author":"Kapczynski","year":"2013","journal-title":"Dev Comp Immunol"},{"key":"10.1016\/j.vaccine.2024.04.088_b0200","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1637\/10173-041012-ResNote.1","article-title":"Potency of a recombinant NDV-H5 vaccine against various HPAI H5N1 virus challenges in SPF chickens","volume":"56","author":"Lardinois","year":"2012","journal-title":"Avian Dis"},{"key":"10.1016\/j.vaccine.2024.04.088_b0205","doi-asserted-by":"crossref","first-page":"e6509","DOI":"10.1371\/journal.pone.0006509","article-title":"Immunization of chickens with Newcastle disease virus expressing H5 hemagglutinin protects against highly pathogenic H5N1 avian influenza viruses","volume":"4","author":"Nayak","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2024.04.088_b0210","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1637\/8416-072308-Reg.1","article-title":"Vaccination with Newcastle disease virus vectored vaccine protects chickens against highly pathogenic H7 avian influenza virus","volume":"53","author":"Schr\u00f6er","year":"2009","journal-title":"Avian Dis"},{"key":"10.1016\/j.vaccine.2024.04.088_b0215","doi-asserted-by":"crossref","first-page":"7401","DOI":"10.1128\/JVI.00031-15","article-title":"Newcastle Disease Virus-Vectored H7 and H5 Live Vaccines Protect Chickens from Challenge with H7N9 or H5N1 Avian Influenza Viruses","volume":"89","author":"Liu","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2024.04.088_b0220","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.vaccine.2020.12.018","article-title":"Global production capacity of seasonal and pandemic influenza vaccines in 2019","volume":"39","author":"Sparrow","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.04.088_b0225","article-title":"Newcastle Disease Virus as a Vaccine Vector for 20 Years: A Focus on Maternally Derived Antibody Interference","volume":"8","author":"Hu","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2024.04.088_b0230","doi-asserted-by":"crossref","unstructured":"Degefa T, Dadi L, Yami A, K GM, Nassir M. Technical and economic evaluation of different methods of Newcastle disease vaccine administration. J Vet Med A Physiol Pathol Clin Med. 2004;51:365-9.","DOI":"10.1111\/j.1439-0442.2004.00658.x"},{"key":"10.1016\/j.vaccine.2024.04.088_b0235","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1637\/10207-041512-Review.1","article-title":"DIVA vaccination strategies for avian influenza virus","volume":"56","author":"Suarez","year":"2012","journal-title":"Avian Dis"},{"key":"10.1016\/j.vaccine.2024.04.088_b0240","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1637\/7226-062204r","article-title":"Development of enzyme-linked immunosorbent assay with nucleoprotein as antigen for detection of antibodies to avian influenza virus","volume":"48","author":"Jin","year":"2004","journal-title":"Avian Dis"},{"key":"10.1016\/j.vaccine.2024.04.088_b0245","doi-asserted-by":"crossref","first-page":"6361","DOI":"10.1016\/j.vaccine.2018.09.015","article-title":"Maternal antibody inhibition of recombinant Newcastle disease virus vectored vaccine in a primary or booster avian influenza vaccination program of broiler chickens","volume":"36","author":"Bertran","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.04.088_b0250","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1038\/s41598-020-59124-x","article-title":"A recombinant avian paramyxovirus serotype 3 expressing the hemagglutinin protein protects chickens against H5N1 highly pathogenic avian influenza virus challenge","volume":"10","author":"Shirvani","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2024.04.088_b0255","doi-asserted-by":"crossref","first-page":"16854","DOI":"10.1038\/s41598-018-35337-z","article-title":"Co-expression of the Hemagglutinin and Neuraminidase by Heterologous Newcastle Disease Virus Vectors Protected Chickens against H5 Clade 2.3.4.4 HPAI Viruses","volume":"8","author":"Cho","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2024.04.088_b0260","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1637\/8735-032509-Reg.1","article-title":"Protective dose of a recombinant Newcastle disease LaSota-avian influenza virus H5 vaccine against H5N2 highly pathogenic avian influenza virus and velogenic viscerotropic Newcastle disease virus in broilers with high maternal antibody levels","volume":"54","author":"Sarfati-Mizrahi","year":"2010","journal-title":"Avian Dis"},{"key":"10.1016\/j.vaccine.2024.04.088_b0265","doi-asserted-by":"crossref","first-page":"e83161","DOI":"10.1371\/journal.pone.0083161","article-title":"Immunization with a thermostable newcastle disease virus K148\/08 strain originated from wild mallard duck confers protection against lethal viscerotropic velogenic newcastle disease virus infection in chickens","volume":"8","author":"Jeong","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2024.04.088_b0270","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1637\/10043-122011-Reg.1","article-title":"Characterization of live LaSota vaccine strain-induced protection in chickens upon early challenge with a virulent Newcastle disease virus of heterologous genotype","volume":"56","author":"Cornax","year":"2012","journal-title":"Avian Dis"},{"key":"10.1016\/j.vaccine.2024.04.088_b0275","doi-asserted-by":"crossref","first-page":"9967","DOI":"10.1128\/JVI.01165-16","article-title":"Pathogenicity and Transmission of H5 and H7 Highly Pathogenic Avian Influenza Viruses in Mallards","volume":"90","author":"Pantin-Jackwood","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2024.04.088_b0280","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.3201\/eid\/1706.101406","article-title":"Novel reassortant highly pathogenic avian influenza (H5N5) viruses in domestic ducks","volume":"17","author":"Gu","year":"2011","journal-title":"China Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2024.04.088_b0285","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1080\/22221751.2020.1738903","article-title":"Live bird markets as evolutionary epicentres of H9N2 low pathogenicity avian influenza viruses in Korea","volume":"9","author":"Youk","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.vaccine.2024.04.088_b0290","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1128\/JVI.76.6.2730-2738.2002","article-title":"High-level primary CD8(+) T-cell response to human immunodeficiency virus type 1 gag and env generated by vaccination with recombinant vesicular stomatitis viruses","volume":"76","author":"Haglund","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2024.04.088_b0295","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0140-6736(06)68076-8","article-title":"Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice","volume":"367","author":"Hoelscher","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2024.04.088_b0300","doi-asserted-by":"crossref","first-page":"979","DOI":"10.4049\/jimmunol.2101147","article-title":"Duck CD8(+) T Cell Response to H5N1 Highly Pathogenic Avian Influenza Virus Infection In Vivo and In Vitro","volume":"209","author":"Dai","year":"2022","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2024.04.088_b0305","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.dci.2011.02.011","article-title":"Immunoglobulin genetics and antibody responses to influenza in ducks","volume":"35","author":"Magor","year":"2011","journal-title":"Dev Comp Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24005279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24005279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T07:25:43Z","timestamp":1718004343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24005279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":61,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0264410X24005279"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.04.088","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of live and inactivated recombinant Newcastle disease virus vaccines expressing clade 2.3.4.4b H5 hemagglutinin against H5N1 highly pathogenic avian influenza in SPF chickens, Broilers, and domestic ducks","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.04.088","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}